A serum pattern predictive of breast cancer.

被引：0
作者：
Mansfield, B
Shriver, CD
Yip, P
Hitt, B
Hooke, J
Somiari, S
Flynn, J
Liebman, M
机构：
[1] Correl Syst Inc, Bethesda, MD USA
[2] Walter Reed Army Med Ctr, Clin Breast Care Project, Washington, DC 20307 USA
[3] Windber Res Inst, CBCP, Windber, PA USA
[4] Landstuhl RMC, CBCP, Landstuhl, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：848S / 848S
页数：1
相关论文
共 50 条
[31]   Homocysteine and breast cancer. [J].
Germano, P. B. M. R. ;
Silva, A. G. ;
Madeira, M. ;
Matlar, A. ;
Joo, Y. K. ;
Souzo, F. G. ;
Stavale, J. N. ;
D'Almeida, V ;
Shinjo, S. M. O. ;
Gebrim, L. H. ;
Correa, M. ;
Jasiulionis, M. G. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 :S43-S43
[32]   The changing pattern of oesophagogastric cancer. [J].
Wayman, J ;
Craig, DJ ;
Biggin, CS ;
Raimes, SA ;
Griffin, SM .
GUT, 1997, 40 :W30-W30
[33]   Nutritional pattern of women with respect to the estrogen and progesterone receptor status of their breast cancer. [J].
Krawinkel, MB ;
Ringsdorf, U ;
Hebestreit, A ;
Mann, M ;
Boedecker, RH .
JOURNAL OF NUTRITION, 2003, 133 (11) :3851S-3852S
[34]   Serum PINP, an index of bone turnover, but not bone mineral density, may be predictive of bone metastases in women with primary operable breast cancer. [J].
McCloskey, E ;
Kanis, J ;
Paterson, A ;
Powles, T ;
Beneton, M ;
Tahtela, R ;
Atula, S ;
Nevalainen, J .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 :S142-S142
[35]   The role of serum osteopontin (OPN) as a prognostic and predictive marker in patients with advanced gastric cancer. [J].
Yazici, O. ;
Akbulut, H. ;
Akgun, N. ;
Utkan, G. ;
Yalcin, B. ;
Icli, F. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[36]   Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance [J].
Catalina Trejo-Becerril ;
Luis F Oñate-Ocaña ;
Lucía Taja-Chayeb ;
América Vanoye-Carlo ;
Lucely Cetina ;
Alfonso Duenas-Gonzalez .
BMC Cancer, 5
[37]   Serum ErbB-2 as a sensitive marker for monitoring recurrent breast cancer. [J].
Kitoh, T ;
Sugano, K ;
Ushiama, M ;
Fukutomi, F ;
Tsuda, H ;
Ohkura, H .
CLINICAL CHEMISTRY, 1999, 45 (06) :A110-A111
[38]   The relation between serum cholesterol and mammographic density as a risk factor for breast cancer. [J].
Tamburrini, A-L ;
Friedenreich, C. M. ;
Courneya, K. S. ;
Jones, C. ;
Patten, S. ;
Yasui, Y. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) :S146-S146
[39]   Tissue and serum expression of c-erbB-2 protein in breast cancer. [J].
Covello, M ;
Labriola, A ;
Venneri, MT ;
Italia, A ;
Zito, A ;
Marzullo, F ;
Quaranta, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) :618-618
[40]   Detection of a novel, tumor-associated protein in the serum of women with breast cancer. [J].
Szaro, R ;
Sarracino, D ;
Cheng, F ;
Purnickescu, J ;
Hass, M .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) :1198S-1198S
12345